Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets

Clinical trial NCT07234877 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07234877
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2026-11-01
Primary completion: 2032-01-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.